IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 71 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | -44.6% | 82,472 | -32.5% | 0.00% | – |
| Q2 2022 | $56,000 | +100.0% | 122,238 | +151.7% | 0.00% | – |
| Q4 2021 | $28,000 | -79.1% | 48,568 | -56.4% | 0.00% | – |
| Q2 2021 | $134,000 | -77.9% | 111,383 | -76.1% | 0.00% | – |
| Q1 2021 | $605,000 | -54.9% | 465,644 | +27.5% | 0.00% | -100.0% |
| Q4 2020 | $1,341,000 | +148.8% | 365,325 | +45.0% | 0.00% | 0.0% |
| Q3 2020 | $539,000 | -50.5% | 251,972 | -58.5% | 0.00% | 0.0% |
| Q2 2020 | $1,088,000 | +66.1% | 607,850 | +22.5% | 0.00% | 0.0% |
| Q1 2020 | $655,000 | -32.0% | 496,070 | -6.2% | 0.00% | 0.0% |
| Q4 2019 | $963,000 | -64.6% | 529,058 | -43.8% | 0.00% | -75.0% |
| Q3 2019 | $2,722,000 | +6.4% | 942,136 | -1.7% | 0.00% | 0.0% |
| Q2 2019 | $2,559,000 | +66.7% | 958,570 | +59.2% | 0.00% | +100.0% |
| Q1 2019 | $1,535,000 | -8.0% | 602,028 | -0.1% | 0.00% | -33.3% |
| Q4 2018 | $1,669,000 | -57.7% | 602,639 | +36.1% | 0.00% | -40.0% |
| Q3 2018 | $3,945,000 | – | 442,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 486,604 | $1,348,000 | 0.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 445,558 | $1,234,000 | 0.14% |
| Baker Brothers Advisors | 4,836,237 | $13,396,000 | 0.11% |
| Kassirer Asset Management Corp | 19,341 | $54,000 | 0.05% |
| Quantitative Systematic Strategies LLC | 23,427 | $65,000 | 0.02% |
| MYCIO WEALTH PARTNERS, LLC | 55,815 | $155,000 | 0.01% |
| Assenagon Asset Management S.A. | 416,241 | $1,153,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 165,626 | $459,000 | 0.01% |
| Candriam S.C.A. | 290,000 | $803,000 | 0.01% |
| ZACKS INVESTMENT MANAGEMENT | 168,781 | $468,000 | 0.01% |